Access the full text.
Sign up today, get DeepDyve free for 14 days.
F. Feit, M. Brooks, G. Sopko, N. Keller, A. Rosen, R. Krone, P. Berger, R. Shemin, M. Attubato, David Williams, R. Frye, K. Detre (2000)
Long-Term Clinical Outcome in the Bypass Angioplasty Revascularization Investigation Registry Comparison With the Randomized TrialCirculation, 101
J. Rodríguez-Feo, F. González-Fernández, S. Casado, J. Rubio, I. Millás, M. García-Durán, L. Rico, J. Farré, L. Miguel, A. López-Farré (1998)
Inducible nitric oxide synthase protein expression after in vivo endothelial denudation of the rat carotid artery: role of the plateletsJournal of the American College of Cardiology, 31
F. Sasso, O. Carbonara, R. Nasti, B. Campana, R. Marfella, M. Torella, Giannantonio Nappi, R. Torella, D. Cozzolino (2004)
Glucose metabolism and coronary heart disease in patients with normal glucose tolerance.JAMA, 291 15
E. Belle, C. Bauters, E. Hubert, J. Bodart, K. Abolmaali, T. Meurice, E. Mcfadden, J. Lablanche, M. Bertrand (1997)
Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels.Circulation, 96 5
A. Abizaid, M. Costa, M. Centemero, A. Abizaid, V. Legrand, R. Limet, G. Schuler, F. Mohr, W. Lindeboom, A. Sousa, J. Sousa, B. Hout, P. Hugenholtz, F. Unger, P. Serruys (2001)
Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of Multivessel Coronary Disease PatientsCirculation, 104
A. Abizaid, M. Costa, M. Centemero, A. Abizaid, V. Legrand, R. Limet, G. Schuler, F. Mohr, W. Lindeboom, A. Sousa, J. Sousa, B. Hout, P. Hugenholtz, F. Unger, P. Serruys (2001)
Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of Multivessel Coronary Disease Patients: Insights From the Arterial Revascularization Therapy Study (ARTS) TrialCirculation: Journal of the American Heart Association, 104
K. Detre, R. Holubkov, S. Kelsey, M. Cowley, K. Kent, David Williams, R. Myler, D. Faxon, D. Holmes, M. Bourassa, P. Block, A. Gosselin, L. Bentivoglio, L. Leatherman, G. Dorros, S. King, J. Galichia, M. Al-Bassam, Martin Leon, T. Robertson, E. Passamani (1988)
Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry.The New England journal of medicine, 318 5
A. Violaris, R. Melkert, J. Herrman, P. Serruys (1996)
Role of angiographically identifiable thrombus on long-term luminal renarrowing after coronary angioplasty: a quantitative angiographic analysis.Circulation, 93 5
D. Halon, A. Merdler, M. Flugelman, G. Shifroni, N. Khader, A. Shiran, J. Shahla, B. Lewis (1998)
Importance of diabetes mellitus and systemic hypertension rather than completeness of revascularization in determining long-term outcome after coronary balloon angioplasty (the LDCMC registry). Lady Davis Carmel Medical Center.The American journal of cardiology, 82 5
Feit Feit, Brooks Brooks, Sopko Sopko (2000)
Long‐term clinical outcome in the Bypass Angioplasty Revascularization Investigation Registry: Comparison with the randomized trial. BARI InvestigatorsCirculation, 101
S. Okazaki, T. Yokoyama, K. Miyauchi, K. Shimada, T. Kurata, Hitoshi Sato, H. Daida (2004)
Early Statin Treatment in Patients With Acute Coronary Syndrome: Demonstration of the Beneficial Effect on Atherosclerotic Lesions by Serial Volumetric Intravascular Ultrasound Analysis During Half a Year After Coronary Event: The ESTABLISH StudyCirculation, 110
S. Haffner, S. Lehto, T. Rönnemaa, K. Pyörälä, M. Laakso (1998)
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.The New England journal of medicine, 339 4
J. Mehilli, A. Kastrati, H. Schühlen, A. Dibra, F. Dotzer, N. Beckerath, H. Bollwein, J. Pache, J. Dirschinger, Peter Berger, A. Schömig (2004)
Randomized Clinical Trial of Abciximab in Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions After Treatment With a High Loading Dose of ClopidogrelCirculation, 110
P. Keelan, J. Johnston, T. Koru-Sengul, K. Detre, David Williams, J. Slater, P. Block, D. Holmes (2003)
Comparison of in-hospital and one-year outcomes in patients with left ventricular ejection fractionsThe American journal of cardiology, 91 10
C. Briguori, A. Colombo, F. Airoldi, A. Violante, A. Focaccio, P. Balestrieri, Pietro Elia, B. Golia, S. Lepore, G. Riviezzo, P. Scarpato, M. Librera, E. Bonizzoni, B. Ricciardelli (2004)
Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction.European heart journal, 25 20
I. Moussa, M. Leon, D. Baim, W. O’Neill, J. Popma, M. Buchbinder, J. Midwall, C. Simonton, Emily Keim, Patrick Wang, R. Kuntz, J. Moses (2004)
Impact of Sirolimus-Eluting Stents on Outcome in Diabetic Patients: A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) SubstudyCirculation: Journal of the American Heart Association, 109
K. Kip, D. Faxon, K. Detre, W. Yeh, S. Kelsey, J. Currier (1996)
Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.Circulation, 94 8
M. Bourassa, R. Frye, S. King, K. Detre, E. Alderman, K. Andrews, G. Sopko (1996)
Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease.The New England journal of medicine, 335 4
C. Grines, D. Cox, G. Stone, Eulogio García, L. Mattos, A. Giambartolomei, B. Brodie, O. Madonna, M. Eijgelshoven, A. Lansky, W. O’Neill, M. Morice (1999)
Coronary Angioplasty with or without Stent Implantation for Acute Myocardial InfarctionThe New England Journal of Medicine, 341
G. Barsness, E. Peterson, E. Ohman, C. Nelson, E. DeLong, J. Reves, Peter Smith, R. Anderson, Robert Jones, D. Mark, R. Califf (1997)
Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty.Circulation, 96 8
F. Zijlstra, M. Boer, J. Hoorntje, S. Reiffers, J. Reiber, H. Suryapranata (1993)
A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction.The New England journal of medicine, 328 10
G. Stone, C. Grines, D. Cox, Eulogio García, J. Tcheng, J. Griffin, G. Guagliumi, T. Stuckey, M. Turco, J. Carroll, B. Rutherford, A. Lansky (2002)
Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.The New England journal of medicine, 346 13
David Williams, R. Holubkov, W. Yeh, M. Bourassa, M. Al-Bassam, P. Block, P. Coady, H. Cohen, M. Cowley, G. Dorros, D. Faxon, D. Holmes, A. Jacobs, S. Kelsey, S. King, R. Myler, J. Slater, V. Staněk, H. Vlachos, K. Detre (2000)
Percutaneous Coronary Intervention in the Current Era Compared With 1985–1986: The National Heart, Lung, and Blood Institute RegistriesCirculation: Journal of the American Heart Association, 102
Mandeep Singh, Peter Berger, H. Ting, C. Rihal, Stephanie Wilson, R. Lennon, G. Reeder, J. Bresnahan, David Holmes (2001)
Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current era (the Mayo Clinic experience).The American journal of cardiology, 88 10
M. Roffi, D. Chew, D. Mukherjee, Deepak Bhatt, J. White, C. Heeschen, C. Hamm, D. Moliterno, R. Califf, H. White, N. Kleiman, P. Théroux, E. Topol (2001)
Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary SyndromesCirculation: Journal of the American Heart Association, 104
S. Marso, A. Lincoff, S. Ellis, Deepak Bhatt, J. Tanguay, N. Kleiman, T. Hammoud, J. Booth, S. Sapp, E. Topol (1999)
Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy.Circulation, 100 25
J. Willerson (1996)
Appointment of New Associate Editor for CirculationCirculation, 94
A. Mokdad, B. Bowman, E. Ford, F. Vinicor, J. Marks, J. Koplan (2001)
The continuing epidemics of obesity and diabetes in the United States.JAMA, 286 10
Lancet, 352
E. Topol (1998)
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockadeThe Lancet, 352
V. Mathew, B. Gersh, B. Williams, W. Laskey, J. Willerson, R. Tilbury, B. Davis, D. Holmes (2004)
Outcomes in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention in the Current Era: A Report From the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) TrialCirculation: Journal of the American Heart Association, 109
E. Alderman, K. Kip, P. Whitlow, T. Bashore, D. Fortin, M. Bourassa, J. Lésperance, L. Schwartz, M. Stadius (2004)
Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI).Journal of the American College of Cardiology, 44 4
K. Narayan, J. Boyle, T. Thompson, Stephen Sorensen, D. Williamson (2003)
Lifetime risk for diabetes mellitus in the United States.JAMA, 290 14
D. Fischman, M. Leon, D. Baim, R. Schatz, M. Savage, I. Penn, K. Detre, L. Veltri, D. Ricci, M. Nobuyoshi (1994)
A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators.The New England journal of medicine, 331 8
David Williams, E. Braunwald, B. Thompson, B. Sharaf, C. Buller, G. Knatterud (1996)
Results of percutaneous transluminal coronary angioplasty in unstable angina and non-Q-wave myocardial infarction. Observations from the TIMI IIIB Trial.Circulation, 94 11
Deepak Bhatt, S. Marso, A. Hirsch, P. Ringleb, W. Hacke, E. Topol (2002)
Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus.The American journal of cardiology, 90 6
Grines Grines, Cox Cox, Stone Stone (1995)
Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study GroupN Engl J Med, 341
O. Manfrini, C. Pizzi, G. Morgagni, F. Fontana, R. Bugiardini (2004)
Effect of pravastatin on myocardial perfusion after percutaneous transluminal coronary angioplasty.The American journal of cardiology, 93 11
P. Feyter, M. brand, GertJan Jaarman, R. Domburg, P. Serruys, H. Suryapranata (1991)
Acute Coronary Artery Occlusion During and After Percutaneous Transluminal Coronary Angioplasty: Frequency, Prediction, Clinical Course, Management, and Follow‐upCirculation, 83
P. Serruys, P. Jaegere, F. Kiemeneij, C. Macaya, W. Rutsch, G. Heyndrickx, H. Emanuelsson, J. Marco, V. Legrand, P. Materne, J. Belardi, U. Sigwart, A. Colombo, J. Goy, P. Heuvel, J. Delcán, M. Morel (1994)
A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group.The New England journal of medicine, 331 8
Deepak Bhatt, S. Marso, A. Lincoff, K. Wolski, S. Ellis, E. Topol (2000)
Abciximab reduces mortality in diabetics following percutaneous coronary intervention.Journal of the American College of Cardiology, 35 4
O'Neill Ww (1998)
Multivessel balloon angioplasty should be abandoned in diabetic patientsJournal of the American College of Cardiology, 31
N Engl J Med., 335
We sought to determine if advances in percutaneous coronary intervention (PCI) are associated with better outcomes among patients with diabetes mellitus (DM). Patients with DM enrolled in the National Heart, Lung, and Blood Institute (NHLBI) early PTCA Registry (1985–1986) were compared to those in the subsequent contemporary Dynamic Registry (1999–2002) for in‐hospital and one‐year cardiovascular outcomes. The study population included 945 adults with DM, 325 from the PTCA Registry and 620 from the Dynamic Registry. Multivariable Cox regression models were built to estimate the risk of clinical events. Dynamic Registry patients were older, had more noncardiac comorbidities, and a lower mean ejection fraction (50.5% vs 57.8%, P ≤ 0.001) compared to the PTCA Registry patients. The incidence of in‐hospital mortality (1.9% vs 4.3%, P ≤ 0.05), myocardial infarction (MI) (1.0% vs 7.4%, P ≤ 0.001), and coronary artery bypass grafting (CABG) (0.8% vs 6.2%, P ≤ 0.001) were all significantly lower and independent of the use of stents. One‐year adverse events including MI (4.9% vs 11.0%, P ≤ 0.001), CABG (6.4% vs 15.0%, P ≤ 0.001), and need for repeat revascularization (18.7% vs 33.3%, P ≤ 0.001) were all lower in the Dynamic Registry. The relative risk of death at 1 year was significantly less for patients in the Dynamic Registry (RR 0.56, 0.34; 0.92, P = 0.02). Although Dynamic Registry patients with diabetes had more advanced coronary disease, in‐hospital and late adverse events were lower. A combination of the use of stents and an increase in adjunctive medical therapy are likely responsible for the observed improvements in outcomes in contemporary PCI.
Journal of Interventional Cardiology – Wiley
Published: Dec 1, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.